|
|
News Breaks | | | | February 5, 2013 | | 07:45 EDT |  | HZNP | Horizon Pharma receives additional U.S. patent allowance for Duexis
Horizon Pharma announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Serial No. 13/620,150 entitled "Stable Compositions of Famotidine and Ibuprofen" with claims that cover Duexis tablets. Duexis is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers. | |
|
News For HZNP From The Last 14 Days Check below for free stories on HZNP the last two weeks. |
|
|
| May 10, 2013 | | 06:34 EDT |  | HZNP | Horizon Pharma reports Q1 adjusted EPS (30c), consensus (35c)
 Subscribe for More Information | |
|
|
|
|
|
|
